Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

Quantum technologies are getting momentum in the EU

On February 27 Austria, Bulgaria, Denmark and Romania have agreed to work together with 20 other EU Member States towards the development of a...

find out more ›

The Avicenna Alliance answers the consultation for Europe’s Beating Cancer Plan

On 3 March 2020, the Avicenna Alliance has submitted feedback on the roadmap of Europe’s Beating Cancer Plan. With...

find out more ›

European Commission's Data Strategy mentions benefits of CM&S and digital twins

On 19 February, the European Commission has released a communication addressing the European strategy for data which...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up